Article Details

BMS' Opdivo-Yervoy improves OS in hepatocellular carcinoma trial

Retrieved on: 2024-06-05 17:22:12

Tags for this article:

Click the tags to see associated articles and topics

BMS' Opdivo-Yervoy improves OS in hepatocellular carcinoma trial. View article details on hiswai:

Excerpt

The gold standard of business intelligence. Find out more. Related Company Profiles. Bristol-Myers Squibb Co · View all. Participants were randomised ...

Article found on: www.clinicaltrialsarena.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo